the Global Mycoplasma Testing market is accounted for $427.2 million in 2016 and is expected to reach $911.7 million by 2022 growing at a CAGR of 13.5% from 2016 to 2022. Rising R&D investments in life sciences, increasing healthcare expenditure levels, increased number of patients suffering from infectious diseases, rapidly increasing new drug launches, increasing applications of PCR technologies in the field of life science, growing biotechnology & pharmaceutical companies, technological advancements and increasing government support are some of the factors favouring the mycoplasma testing market.
- Advertising -
However, stringent government regulations and high degree of consolidation for new entrants are hampering the market.
Polymerase Chain Reaction (PCR) technology is projected to witness substantial breakthrough advancements over the coming decade and is expected to provide lucrative avenues of growth.
- Advertising -
Pharmaceutical and biotechnology companies hold the largest share in end users segment. Contract research organizations are anticipated to grow at a faster pace during the forecast period.
North America is the largest market for mycoplasma testing market due to increasing demand for fast, accurate and affordable diagnosis in healthcare. In addition, spending in R&D activities is expected to enhance developments and rising government funding for pharmaceutical and biotechnology sector in North America is also boosting the growth of mycoplasma testing markets.
Asia Pacific is expected to witness fastest growth on account of rapidly increasing demand for advanced healthcare technologies, funding initiatives generated by the Indian government to promote R&D activities in biopharmaceutical industries.
Some of the significant players in global mycoplasma testing market are Abbott, American Type Culture Collection, Beckman Coulter/Danaher, Becton Dickinson, Biological Industries, Israel Beit Haemek Ltd., Bionique Testing Laboratories, Inc., Charles River Laboratories International, Inc., InvivoGen, Lonza Group Ltd., Merck KGaA, Promo Cell GmbH, Qiagen, Roche, Sigma-Aldrich and Thermo Fisher Scientific, Inc.
Enzyme-Linked Immunosorbent Assay (ELISA)
Microbial Culture Techniques
Polymerase Chain Reaction (PCR)
Product Types Covered:
Kits & Reagents
Elimination Kits & Reagents
Nucleic Acid Detection Kits
Standards & Controls
Other Kits & Reagents
End of Production Cells Testing
Cell Line Testing
End Users Covered:
Academic Research Institutes
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
Other End Users
o Rest of Europe
Rest of Asia Pacific
Rest of the World
What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements
Category: Market Research Publishers and RetailersCompany profile: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...
For more information: